COPD Clinical Trials

Showing 661-680 of 1,501 trials

An Efficacy and Safety Profile of Inhaled TV48108 in Healthy Volunteers and COPD Patients

NCT02315144

The primary objective of the study is to characterize the safety profile and duration of bronchodilation of a single dose of inhaled TV48108.

Chronic Obstructive Pulmonary Disease

Teva Branded Pharmaceutical Products R&D, Inc.61 participantsStarted Apr 2015

Medford, Oregon, United States • Spartanburg, South Carolina, United States • Clayton, Australia +4 more locations

TERMINATEDPhase 1

Study in Healthy Volunteers and COPD Patients to Evaluate the Efficacy and Safety of Inhaled TV46017

NCT02315131

The primary objective of the study is to characterize the safety profile and duration of bronchodilation of a single dose of inhaled TV46017

Chronic Obstructive Pulmonary Disease (COPD

Teva Branded Pharmaceutical Products R&D, Inc.53 participantsStarted Mar 2015

St Louis, Missouri, United States • Raleigh, North Carolina, United States • Adelaide, Australia +4 more locations

WITHDRAWNPhase 2

A Study of 3 Doses of Tiotropium Hydrofluoralkane (HFA) Breath Actuated Inhaler (BAI), in Patients With Chronic Obstructive Pulmonary Disease

NCT02203474

The primary objective of this study is to demonstrate the superiority of tiotropium hydrofluoroalkane (HFA) breath actuated inhaler (BAI) to placebo HFA BAI following repeated, once-daily dosing.

Chronic Obstructive Pulmonary DiseaseCOPD

Teva Branded Pharmaceutical Products R&D, Inc.Started Aug 2014

An Efficacy and Safety Profile of Inhaled TV48108 in Healthy Volunteers and COPD Patients

Study in Healthy Volunteers and COPD Patients to Evaluate the Efficacy and Safety of Inhaled TV46017

A Study of 3 Doses of Tiotropium Hydrofluoralkane (HFA) Breath Actuated Inhaler (BAI), in Patients With Chronic Obstructive Pulmonary Disease

Related Searches

Functional Proteomics of Alveolar Macrophages

A Phase II, 5-way Cross-over Study to Evaluate the Pharmacodynamics of "Nexthaler" Dry Powder Inhaler in COPD Patients

2-arm Parallel Group Study of Fixed Combination of CHF 5993 vs Ultibro® in COPD Patients

Pharmacokinetic Interaction Study of Glycopyrrolate and Formoterol in Healthy Volunteers

A Study to Investigate the Pharmacokinetics, Safety and Tolerability of CHF 5993 pMDI in Subjects With Renal Impairment.

Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate Versus Foster® in COPD

An Open Label Placebo Study To Assess The Inhalation Profile Obtained By Acoustic Monitoring In COPD Patients Using The NEXThaler DPI

The Effect of HFNC on Exercise Capacity Compared to VM in COPD Patients Recovering From Acute Evacerbation

A Proof-of-mechanism Study of Multiple, Oral Doses of Fevipiprant (QAW039) in COPD Patients With Eosinophilia

Study on the Etiology, Risk Factors and Pathogenesis of COPD Based on Clinical Bioinformatics

Intervention for Resistant Pregnant Smokers

Respiratory Disorders Non-invasive Monitoring of Work of Breathing in Outpatients

Switch of Budesonide-formoterol Dry Powder Inhalers at Pharmacy in Norway

Intra- and Inter-evaluator Reproducibility of Upper Limb Strength Measures in Patients With COPD

Spinal Structure and Mobility in Chronic Obstructive Pulmonary Disease

Prediction of Exacerbations and Management of COPD Patients With SAH Based on Millimeter Wave Radar Monitoring

Capnometry-Assisted Breathing Training for COPD